Edward Charles
Chief Executive Officer at Franklin Road Ltd.
Profile
Edward Charles has held the following positions in his career: Vice Chairman-Supervisory Board at APEIRON Biologics AG since 2021, and Managing Director at Franklin Road Ltd.
Edward Charles active positions
Companies | Position | Start |
---|---|---|
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Director/Board Member | 2020-10-13 |
Franklin Road Ltd.
Franklin Road Ltd. Financial ConglomeratesFinance Franklin Road Ltd. engages in the provision of investment services. The company was founded on May 15, 2020 and is headquartered in Saint Peter Port, the United Kingdom. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Health Technology |
Franklin Road Ltd.
Franklin Road Ltd. Financial ConglomeratesFinance Franklin Road Ltd. engages in the provision of investment services. The company was founded on May 15, 2020 and is headquartered in Saint Peter Port, the United Kingdom. | Finance |
- Stock Market
- Insiders
- Edward Charles